Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytisinicline and Exercise for Smoking Cessation
NCT06579846Phase 4Not yet recruiting
- Sponsor
- Maimónides Institute of Biomedical Research of Córdoba
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of cytisinicline in nicotine dependence, sponsored by Maimónides Institute of Biomedical Research of Córdoba. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
cytisinicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT06579846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06579846.